rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

Starling Oncology, Inc.

STLN · Nasdaq

Health CareProviders & FacilitiesLeading

STLN stood above a rising 150-day average in 34 of the last 52 weekly readings, including each of the last 25 weeks. It is 26.9% above that average now. Providers & Facilities: 45% of its 53 stocks in an uptrend (−6 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Leading
Weeks in an uptrend
25 in a row
Industry in uptrend
45% -6 in 4 wk
Insider buys, 12 months
$5.4M
Insider sales, 12 months
$5.4M
Officials’ trades on record
0
Institutions holding
114 (+6)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 34 of 52 weeks.

17 Apr – 16 Oct
26%43%59%Apr 26Jun 26Jul 26Sep 26Oct 26

Providers & Facilities: About half its stocks are in an uptrend and the share has been slipping. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
−$19.8M$0Nov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

No member of Congress or official has disclosed a trade in it.

Insiders

Buy orders, 12 months16
Sale orders, 12 months8
Buyers · sellers1 · 5
WhoDidSharesTraded
Brad HivelyDirectorsold298,853at $6.5121 Aug 2026filed 24 Aug 2026
Jorey Chernett10% ownerbought12,000at $6.5414 Aug 2026filed 17 Aug 2026
Jorey Chernett10% ownersold100at $6.2413 Aug 2026filed 17 Aug 2026
Jorey Chernett10% ownerbought18,000at $5.2721 Jul 2026filed 22 Jul 2026
Yale PodnosChief Medical Officersold17,974at $6.4314 Jul 2026filed 16 Jul 2026
Yale PodnosChief Medical Officersold5,478at $6.3514 Jul 2026filed 16 Jul 2026
Jorey Chernett10% ownerbought15,000at $5.8510 Jul 2026filed 13 Jul 2026
Jorey Chernett10% ownerbought18,000at $5.0223 Jun 2026filed 24 Jun 2026
Yale PodnosChief Medical Officersold23,451at $5.388 Jun 2026filed 9 Jun 2026
Jorey Chernett10% ownerbought12,000at $4.754 Jun 2026filed 5 Jun 2026
Jorey Chernett10% ownerbought33,500at $4.0720 May 2026filed 21 May 2026
Jorey Chernett10% ownerbought30,000at $4.0919 May 2026filed 20 May 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders114+6 on the quarter
New · exited27 · 21
Reported value$213.4M

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BlackRock, Inc.added · filed 7 Aug 20264,749,030$25.8M+333,163+7.5%
DEERFIELD MANAGEMENT COMPANY, L.P.unchanged · filed 14 Aug 20263,360,052$18.2M00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20263,265,531$17.7M-211,250−6.1%
JOSH ARNOLD INVESTMENT CONSULTANT, LLCunchanged · filed 14 Aug 20262,464,359$13.4M00.0%
GEODE CAPITAL MANAGEMENT, LLCadded · filed 12 Aug 20261,899,998$10.3M+142,151+8.1%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 20261,735,337$9.4M+383,438+28.4%
WEXFORD CAPITAL LPunchanged · filed 14 Aug 20261,711,323$9.3M00.0%
STATE STREET CORPadded · filed 7 Aug 20261,552,917$8.4M+91,463+6.3%
Nuveen, LLCadded · filed 11 Aug 20261,408,720$7.6M+1,313,456+1378.8%
RENAISSANCE TECHNOLOGIES LLCadded · filed 13 Aug 20261,365,913$7.4M+463,104+51.3%
31 Mar 2023 – 30 Jun 2026
3171111Mar 23Dec 23Dec 24Sep 25Jun 26

News

No headline names it lately.

Everyone who traded it

Brad Hively Company insiderDirector · last 21 Aug 20264 · 7
Jorey Chernett Company insider10% owner · last 14 Aug 202616 · 0
Anne McGeorge Company insiderDirector · last 27 Jul 20260 · 0
Karen Marie Johnson Company insiderDirector · last 27 Jul 20261 · 0
Kimberly Jo Tzoumakas Company insiderDirector · last 27 Jul 20260 · 0
Mark L. Pacala Company insiderDirector · last 27 Jul 20261 · 1
Mark Stolper Company insiderDirector · last 27 Jul 20260 · 0
Mohit Kaushal Company insiderDirector · last 27 Jul 20260 · 4
Yale Podnos Company insiderChief Medical Officer · last 14 Jul 20261 · 3
Daniel Virnich Company insiderChief Executive Officer · last 21 May 20261 · 1
Robert Ross Carter Company insiderChief Financial Officer · last 21 May 20261 · 1
Jeffrey Langsam Company insiderChief Clinical Officer · last 27 Mar 20260 · 0

Same industry

PACS PACS GroupLeading+18%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Operating profit marginFY 2025 · to 31 Dec 2025-7.2%
Free cash flow marginFY 2025 · to 31 Dec 2025-5.5%
Return on capital employedFY 2025 · to 31 Dec 2025-38.5%
Share count trendFY 2025 · to 5 Mar 2026-0.0%
Cash and equivalentsFY 2025 · to 31 Dec 2025$33.6M
Free cash flowFY 2025 · to 31 Dec 2025−$27.8M

Analyst forecasts

No analyst forecasts yet.